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This drug is listed in United States pharmacopoeia, 2 which recommends non-aqueous titration and HPLC methods for its assay in bulk and tablet formulations, respectively.
UV-visible spectrophotometry is still considered to be a very convenient and low-cost technique, and hence is widely used for the determination of pharmaceuticals in bulk and dosage forms. A review of the literature revealed that charge-transfer complexation reactions between famotidine and π acceptors, such as 1,4-benzoquinone, 3 chloranil, dichlorodicyanobenzoquinone, dichloronitrophenol 4 and p-chloranilic acid, 5 have been recommended for its determination in commercial tablet formulations. Extractive spectrophotometric methods 6 have also been discussed which involve dichloromethane extractable 1:1 ion pair complex between famotidine and each of Bromocresol Green (BCG) and Bromothymol Blue (BTB). Beer's law was obeyed over the concentration ranges of 2.0 -23.6 and 0.7 -8.1 µg mL -1 with molar absorptivities of 5.0 × 10 3 and 1.2 × 10 4 L mol -1 cm -1 for famotidine-BCG and famotidine-BTB, respectively. The famotidine content was determined based on a reaction with sodium nitroprusside and measuring the absorbance at 498 nm. 7 The difference spectrophotometric and quadratic polynomial coefficient methods 8 have been cited in the literature for the determination of famotidine in pharmaceutical preparations.
A number of other techniques, such as HPLC, 9-14 reversedphase HPLC, 15 HPTLC 16 and differential pulse voltammetry, 17 and potentiometric titration, 18 have been reported for the assay of famotidine in commercial dosage forms. Several manipulation steps are involved in some of these methods, which are not simple for the routine analysis of dosage forms.
The present communication describes a kinetically based spectrophotometric method for the determination of famotidine in pharmaceutical formulations. The method involves oxidation of the drug with alkaline potassium permanganate at room temperature and a subsequent measurement of the absorbance at 610 nm. The initial-rate and fixed-time methods are adopted after a full investigation.
Experimental

Apparatus
Spectronic 20 D + Spectrophotometer (Milton Roy, USA) was used to measure the absorbance.
Materials and reagents
Famotidine was kindly provided by Wockhardt Ltd., India, and was used as received. Pharmaceutical preparations of famotidine, such as Topcid (Torrent Pharmaceuticals Ltd.), Famocid (Sun Pharmaceutical Industries Ltd.), Famotin (USV Ltd.) and Facid (Intas Labs Pvt. Ltd.), were purchased from local market. All other reagents used were of analytical grade.
A standard solution of famotidine (1 mg mL -1 ) was prepared by dissolving 100 mg in 0.5 mL of 1 M NaOH, and further diluted to 100 mL with doubly distilled water. A working solution of famotidine (0.1 mg mL -1 ) was prepared by the dilution of 2.5 mL of the standard solution to 25 mL with doubly distilled water. Aqueous solutions of sodium hydroxide (1 M) and potassium permanganate (0.01 M) were prepared in doubly distilled water.
A simple kinetic spectrophotometric method is described for the determination of famotidine. The method is based on the oxidation of the drug with alkaline potassium permanganate. The reaction is followed spectrometrically by measuring the rate of change of the absorbance at 610 nm. The initial-rate and fixed-time (at 12 min) methods are adopted for determining the drug concentration. The calibration graphs are linear in the ranges of 2 -10 µg mL -1 and 1 -8 µg mL A calibration graph was constructed by plotting the logarithm of the initial rate of the reaction vs. the logarithm of the molar concentration of famotidine. In the second procedure, the absorbance measured at a fixed time of 12 min was plotted against the final concentration of famotidine. The content of the drug was calculated either from the calibration graphs or regression equations. Procedure for the determination of famotidine in pharmaceutical formulations. Ten tablets were accurately weighed and powdered. A portion equivalent to 50 mg of famotidine was extracted with methanol by shaking and filtered on Whatman No. 42 filter paper. The filtrate and washings were evaporated to dryness. The residue was dissolved in a minimum volume of 1 M NaOH and diluted according to need. The assay of famotidine was completed by the following recommended procedures.
Results and Discussion
In an alkaline medium, potassium permanganate oxidizes famotidine, resulting in the formation of manganate ion, which showed an absorption peak at 610 nm. Because the intensity of the color increased with time, a kinetically based method was elaborated for the determination of famotidine in dosage forms. The various experimental parameters affecting the formation of the reaction product were optimized.
Effect of the KMnO4 concentration
To study the effect of the KMnO4 concentration, aliquots of famotidine containing 100 µg mL -1 were transferred into a series of 10 mL volumetric flasks, followed by varying volumes of 0.01 M KMnO4 (0.1 -1.0 mL) and 1.5 mL of 1 M NaOH solutions. The absorbance at 610 nm was measured at a fixed time of 16 min. It is apparent from Fig. 1 that the absorbance increased with increasing volume of the KMnO4 solution, and became constant at 0.8 mL. Thus, the adoption of 1.0 ml of 0.01 M KMnO4 in the final solution proved to be adequate for the maximum concentration of famotidine used in the calibration curve.
Effect of the NaOH concentration
The influence of the NaOH concentration on the formation of MnO4 2-was examined critically. It was observed (Fig. 2) that the maximum absorbance of the reactant solution was obtained with 1.2 mL of 1 M NaOH. Hence, an optimum value of 1.5 mL was used throughout the experiment.
Stoichiometry
The combining ratio between potassium permanganate and famotidine was established by limiting the logarithmic method 19 using two sets of experiments. In the first set, the famotidine concentration was varied while keeping a constant KMnO4 concentration; in the second set, the KMnO4 concentration was varied while keeping a constant concentration of famotidine. The logarithms of the absorbance were plotted against the logarithms of the varied concentration (Fig. 3) . The combining molar ratio was obtained from the slope of the curves, and was found to be 1:1 famotidine/KMnO4.
The famotidine contains a thio ether linkage which has an ability to oxidize to the corresponding sulfoxide. Based on literature background and our experimental findings, the reaction mechanism is proposed and given in Scheme 1. 
Initial-rate method
The initial rates of the reaction were determined by measuring the slopes of the initial tangents to the absorbance time curves (Fig. 4) . The order with respect to permanganate was estimated by studying the reaction at different initial concentrations of KMnO4 with a fixed famotidine concentration. A plot of the initial rate, dA/dt, against the initial absorbance was linear while passing through the origin. This indicated that the order of the reaction with respect to permanganate at the start was one. The order with respect to famotidine was obtained by plotting the log initial rate of the reaction vs. the log molar concentration of famotidine, and was found to be unity.
Under the optimized conditions, the concentration of famotidine was determined using an excess of a KMnO4 and NaOH solution with respect to the initial concentration of famotidine. As a consequence, a pseudo zero-order condition was obtained with respect to their concentrations. However, the initial rate of the reaction would follow a pseudo first-order equation,
where C is the concentration of famotidine. The above equation is transformed into logarithmic equation as log(rate) =log ∆A/∆t = log K′ + nlog C.
A regression of the log rate versus log C gave a regression equation, log(rate) = 3.212 + 1.021 × log C, with a correlation coefficient (r) of 0.9971.
The regression equation also confirmed that the reaction is first order with respect to the famotidine concentration. The calibration curve was found to be linear over the range 2 -10 µg mL -1 . The confidence limit for the intercept value at the 95% confidence level was calculated using the relation a ± tSa, 20 and was found to be 3.212 ± 0.0387, which pointed towards a high reproducibility of the method. The detection limit, 21 percent relative standard deviation, standard analytical error and variance were found to be 1.68%, 0.0319, and 3.76 × 10 -4 , respectively. The small value of the variance confirmed the negligible scattering of the calibration data points around the line of the regression.
Fixed-time method
At a preselected fixed time, the absorbance of a green-colored solution containing varying amounts of famotidine was measured at 610 nm. Calibration graphs were constructed by plotting the absorbance against the initial concentration of famotidine at a fixed time of 4, 8, 12 and 16 min. The calibration equations, correlation coefficient, detection limit, variance and molar absorptivity are given in Table 1 . It was observed that the most acceptable values of the relative standard deviation and the intercept were obtained at a fixed time of 12 min, and therefore were considered to be the most suitable time interval for measurements under this condition. The calibration graph was linear over the concentration range of 1 -8 µg mL -1 . A strong correlation also existed between the slope and the 909 ANALYTICAL SCIENCES JUNE 2003, VOL. 19 Table 1 Calibration equations, precision and accuracy at different fixed times for famotidine concentrations in the range of 1 -8 µg mL -1 ± tSa = Confidence limit for intercept. ± tSb = Confidence limit for slope. SAE = Standard analytical error. intercept of the calibration line (at a fixed time of 12 min). This was established by drawing a joint confidence region (Fig. 5) at the 95% confidence level following the method of Mandel and Linnig. 22 It is evident from the figure that the point for which the intercept is zero fell well within the ellipse, thus confirming no significant difference from zero. The validity of the proposed methods was tested by adding a fixed amount of pure drug to preanalyzed dosage forms. The results obtained from the investigations are summarized in Tables 2 and 3 , respectively, which indicated that the common additives and excipients did not interfere with the determination.
The initial-rate method and fixed-time method were applied to the determination of famotidine in commercial dosage forms. The concentration of the drug was computed from the corresponding regression equations. The results (Tables 4 and  5 ) obtained by the proposed method, were compared statistically with that of a reference method, 7 revealing the fact that there is no significant difference in the performance of the methods regarding accuracy and precision. sample of pure famotidine and to Dr. SM Jaweed Mukarram for his valuable cooperation to carry out this work.
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